GH Secretagogue GHRP-2 Increases Body Fat Even in Mice Without NPY — Through Alternative Brain Pathways
GHRP-2 increased fat mass in NPY knockout mice, proving that GH secretagogue-induced adiposity uses hypothalamic agouti-related protein (AgRP) pathways, not just the expected NPY pathway.
Quick Facts
What This Study Found
GHRP-2 increased fat mass in NPY knockout mice, demonstrating that GH secretagogue-induced adiposity is mediated by hypothalamic AgRP rather than NPY, identifying a critical alternative pathway for ghrelin's metabolic effects.
Key Numbers
How They Did This
Animal study comparing GHRP-2 effects on body composition in NPY knockout versus wild-type mice. Fat mass, food intake, and hypothalamic neuropeptide expression measured.
Why This Research Matters
Identifying AgRP as the mediator of ghrelin-induced fat gain provides a more specific therapeutic target. Blocking AgRP could potentially prevent the unwanted weight gain from GH secretagogues.
The Bigger Picture
The appetite/fat-storage system has backup pathways. Blocking one (NPY) doesn't prevent fat gain because another (AgRP) takes over. Effective anti-obesity therapy may need to target multiple pathways.
What This Study Doesn't Tell Us
NPY knockout mice may have compensatory mechanisms. The role of AgRP was inferred rather than directly proven. Other pathways may also contribute.
Questions This Raises
- ?Could AgRP antagonists prevent GH secretagogue-induced weight gain?
- ?Does dual NPY/AgRP targeting produce more effective appetite suppression?
- ?Are other mediators involved beyond NPY and AgRP?
Trust & Context
- Key Stat:
- Backup pathway found Even without NPY, GHRP-2 increased fat through AgRP — the appetite system is redundant, requiring multi-target approaches for obesity treatment
- Evidence Grade:
- Preliminary animal evidence using a definitive genetic approach (NPY knockout) to demonstrate pathway redundancy.
- Study Age:
- Published in 2002. The AgRP pathway has been confirmed as a key mediator of ghrelin's metabolic effects, guiding anti-obesity drug development.
- Original Title:
- GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.
- Published In:
- Endocrinology, 143(2), 558-68 (2002)
- Authors:
- Tschöp, Matthias(4), Statnick, Michael A, Suter, Todd M(2), Heiman, Mark L
- Database ID:
- RPEP-00779
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
Why is it so hard to prevent weight gain from GH peptides?
Because the appetite/fat system has backup pathways. Even without NPY (a major appetite signal), the AgRP pathway fills in. Preventing weight gain may require blocking multiple pathways simultaneously.
What is AgRP?
Agouti-related protein is a brain signal that promotes appetite and fat storage. It works alongside NPY but can function independently, as this study shows. It's now a key target for obesity drug development.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00779APA
Tschöp, Matthias; Statnick, Michael A; Suter, Todd M; Heiman, Mark L. (2002). GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.. Endocrinology, 143(2), 558-68.
MLA
Tschöp, Matthias, et al. "GH-releasing peptide-2 increases fat mass in mice lacking NPY: indication for a crucial mediating role of hypothalamic agouti-related protein.." Endocrinology, 2002.
RethinkPeptides
RethinkPeptides Research Database. "GH-releasing peptide-2 increases fat mass in mice lacking NP..." RPEP-00779. Retrieved from https://rethinkpeptides.com/research/tschop-2002-ghreleasing-peptide2-increases-fat
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.